Trump Holds the Rescheduling Key: Will Marijuana Reform Follow the Patient's Right to Try Path?
Press Release

Trump Holds the Rescheduling Key: Will Marijuana Reform Follow the Patient's Right to Try Path?

From ‘Right to Try' to Cannabis: Trump's Next Breakthrough Could Unlock FDA Trials.

"President Trump's marijuana decision must go beyond politics-patients suffering from Huntington's disease and Multiple Sclerosis have waited nearly a decade for access to MMJ International Holdings' FDA-approved clinical trials. With capsules manufactured and science in place, all that's missing is the DEA stepping aside." stated Duane Boise, CEO MMJ International Holdings.

Read More
This DEA Marijuana Story Is So Bizarre and Twisted! Will President Trump Reschedule?
Press Release

This DEA Marijuana Story Is So Bizarre and Twisted! Will President Trump Reschedule?

Following a landmark court ruling against the Department Of Labor, Duane Boise, CEO of MMJ International Holdings exposes the DEA's identical use of unconstitutional in house courts to paralyze medical cannabis research for Huntington's and Multiple Sclerosis patients.

Read More